[MissingTranslation]
Gefry, a 63-year-old male with type 2 diabetes you have called in to talk about routine screening for diabetic nephropathy.
Gefry, a 63-year-old male with type 2 diabetes you have called in to talk about routine screening for diabetic nephropathy.
To support the C-CHANGE guideline for the role of SGLT2i in patients with heart failure.
To support the C-CHANGE guideline for the role of SGLT2i in patients with heart failure.
To support the updated Diabetes Canada guideline, part of the C-CHANGE CPG, for the role of SGLT2i as kidney protection including tips about other kidney protective agents for patients with advanced nephropathy from type 2 diabetes
To support the updated Diabetes Canada guideline, part of the C-CHANGE CPG, for the role of SGLT2i as kidney protection including tips about other kidney protective agents for patients with advanced nephropathy from type 2 diabetes